The Invesco Perpetual UK Recovery Fund aims to achieve capital growth
Name | % Net Assets |
---|---|
AstraZeneca | 7.9% |
GlaxoSmithKline | 7.1% |
Lloyds TSB | 6.2% |
Vodafone | 5.8% |
Royal Dutch Shell 'B' | 5.5% |
Morrison (W) Supermarkets | 4.3% |
HBOS | 4.3% |
Smith (DS) | 3.6% |
Aviva | 3.5% |
Carnival | 3.5% |
Key | % Net Assets |
---|---|
AstraZeneca | 7.9% |
GlaxoSmithKline | 7.1% |
Lloyds TSB | 6.2% |
Vodafone | 5.8% |
Other | 73% |
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | 12/09/2002 |
---|---|
Fund Manager | Ian Carstairs |
TER | - |
Minimum Investment | |
---|---|
Initial | 500 |
Additional | 100 |
Savings | 20 |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.18 |
You are here: research